A Homodimeric Aptamer Variant Generated from Ligand-Guided Selection Activates the T Cell Receptor Cluster of Differentiation 3 Complex
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 22, 167-178
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institute of General Medical Sciences (SC1 GM122648)
This publication has 54 references indexed in Scilit:
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- CD28 Aptamers as Powerful Immune Response ModulatorsMolecular Therapy Nucleic Acids, 2013
- Antibody-Based Immunotherapy of CancerCell, 2012
- A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemiaNucleic Acids Research, 2010
- The chemistry of irreversible captureAdvanced Drug Delivery Reviews, 2008
- Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating AptamerChemistry & Biology, 2008
- Aptamers in ImmunotherapyHuman Gene Therapy, 2008
- Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in miceJournal of Clinical Investigation, 2008
- Superior structure stability and selectivity of hairpin nucleic acid probes with an L-DNA stemNucleic Acids Research, 2007
- Synthesis and investigation of deoxyribonucleic acid/locked nucleic acid chimeric molecular beaconsNucleic Acids Research, 2007